Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Medivir
Medivir
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination
BioSpace
Mon, 04/17/23 - 11:21 am
Medivir
AACR
fostrox
cancer
AstraZeneca veteran takes up CEO post at Medivir, becoming 4th person to hold the post in quick succession
Fierce Biotech
Mon, 10/25/21 - 10:50 am
Pharma CEOs
Medivir
AstraZeneca
Jens Lindberg
Medivir slashes jobs, projects for cancer focus
BioPharma Dive
Tue, 10/11/16 - 10:34 am
Medivir
layoffs
MIV-711
cancer
Medivir plans year-end split
BioPharma Dive
Thu, 09/1/16 - 09:21 am
Medivir
R&D
reorganization
J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
Bloomberg
Fri, 03/21/14 - 10:21 am
JNJ
hepatitis C
Europe
Medivir
Olysio
Drugmakers, beware of tweets that trigger stock moves
Fierce Pharma
Thu, 12/12/13 - 11:44 am
twitter
social media
Medivir
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thu, 10/24/13 - 06:04 pm
FDA
JNJ
Medivir
hepatitis C
simeprevir
J&J-Medivir’s Drug Works Against Hepatitis C
Bloomberg
Tue, 10/22/13 - 08:36 am
JNJ
Medivir
hepatitis C
simeprevir
FDA
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Mon, 06/3/13 - 10:27 am
hepatitis C
Merck
Gilead
Vertex Pharmaceuticals
JNJ
Medivir
Bristol-Myers Squibb
Gilead-Medivir Hepatitis C Drug Clears Virus in Patients
Bloomberg
Mon, 03/4/13 - 10:59 am
hepatitis C
Gilead
Medivir
sofosbuvir
simeprevir
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
hepatitis C
Gilead Sciences
sofosbuvir
Medivir
TMC435
ACH-1625
Achillion
Lessons From The Liver Meeting: Sagient's John Tucker Names Companies That Could Reignite The Hepatitis C Industry
Seeking Alpha
Fri, 11/30/12 - 12:10 pm
hepatitis C
Achillion
Gilead
Idenix
Merck
Medivir
Vertex Pharmaceuticals
Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover
Bloomberg
Thu, 11/1/12 - 11:49 am
Medivir
hepatitis C
VX-135
Vertex Pharmaceuticals
Medivir Announces TMC435 in an Expanded Clinical Collaboration
Yahoo
Wed, 04/18/12 - 09:14 am
Medivir
TMC435
Janssen
Bristol-Myers Squibb
daclatasvir
hepatitis C
10 Hep C Stocks on Wall Street's Watch List
TheStreet.com
Thu, 09/15/11 - 11:58 am
hepatitis C
Vertex
Merck
Anadyx
Pharmasset
Gilead
Bristol-Myers Squibb
JNJ
Medivir
Achillion
Inhibitex
Indenix
Four Biotech Picks to Fight Hepatitis C
Barron's
Wed, 09/14/11 - 11:07 am
hepatitis C
Achillion
Pharmasset
Inhibitex
Medivir
Vertex
JNJ
J&J Has to Resolve Hepatitis C Drug Conflict, Medivir CEO Says
Bloomberg
Wed, 07/13/11 - 08:23 am
Medivir
JNJ
hepatitis C
Incivek
Tibotec
TMC435
Vertex Pharmaceuticals
Medivir: terms of herpes-drug venture are reset
Marketwatch
Wed, 06/29/11 - 06:57 am
herpes
Medivir
Xerese
Meda
Medivir Shares Gain After Hepatitis C Drug Test Results Released
Bloomberg
Mon, 11/1/10 - 10:09 am
Medivir
hepatitis C
Medivir wins FDA approval for cold sores drug
Trading Markets
Tue, 08/4/09 - 01:39 pm
FDA
Medivir
cold sores
Lipsovir